Home/Filings/4/0001209191-23-010603
4//SEC Filing

Dinsmore Christopher 4

Accession 0001209191-23-010603

CIK 0001741830other

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:21 PM ET

Size

7.3 KB

Accession

0001209191-23-010603

Insider Transaction Report

Form 4
Period: 2023-02-15
Dinsmore Christopher
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2023-02-15+119,882291,292 total
  • Award

    Employee Stock Option (Right to Buy)

    2023-02-15+179,824179,824 total
    Exercise: $2.09Exp: 2033-02-14Common Stock (179,824 underlying)
Footnotes (2)
  • [F1]Includes an aggregate of 8,474 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on the following dates: 959 shares on June 30, 2021, 1,039 shares on December 31, 2021 and 6,476 shares on December 30, 2022.
  • [F2]1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.

Issuer

Kronos Bio, Inc.

CIK 0001741830

Entity typeother

Related Parties

1
  • filerCIK 0001826766

Filing Metadata

Form type
4
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:21 PM ET
Size
7.3 KB